Back to search

North Texas State University

Toxicological Evaluation for the Ocular Administration of Tolrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetes

Abstract

dc:description

Aldose reductase inhibitors (ARI's) have been shown to attenuate or prevent several complications of diabetes in animals. Tolrestat is a potent and unique ARI from Ayerst Laboratories, New York, NY. The efficacy and toxicology of tolrestat via topical ocular administration was examined. Tolrestat effectively enhanced corneal reepithelialization and was efficacious in the prevention of cataracts in the streptozotocin-diabetic rat. Ocular tissues were examined by slit lamp biomicroscopy, scanning and transmission electron microscopy, and light microscopy. Liver and kidney tissue was also examined. The presence of tolrestat was confirmed in urine, feces, and eye specimens, and quantitated in serum. There was no evidence of local or systemic tolrestat induced toxicity. Tolrestat prevented cataract formation at less than one-third the reported oral dose and at approximately one-fiftieth the associated serum concentration in rats. ED-50 and TD-50 calculations indicate that tolrestat is a relatively safe drug by topical ocular administration.

Degree

thesis:*
Grantor dc:publisher
North Texas State University
Year dc:date
1987

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Carney, Gerald R.
Contributors dc:contributor
  • Wimbish, Gary Harold
  • Carnes, James E.
  • Harris, Ben G.
  • Yorio, Thomas

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • Public
  • Carney, Gerald R.
  • Copyright
  • Copyright is held by the author, unless otherwise noted. All rights
Language dc:language
English

Identifiers

dc:identifier.*
Identifier
local-cont-no: 1002715271-Carney_Color
call-no: 379 N81d no.2765
untcat: b1416726
oclc: 18593230
ark: ark:/67531/metadc935757

Chain of custody

source
Harvested from
University of North Texas
Base URL
digital.library.unt.edu/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Carney, Gerald R.. Toxicological Evaluation for the Ocular Administration of Tolrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetes. North Texas State University, 1987. https://digital.library.unt.edu/ark:/67531/metadc935757/